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Abstract Introduction Head injury is a direct determinant of morbidity, disability, and
mortality in the young population. Sedatives and analgesics are commonly used in
patients with brain injury to retrieve an ICP, CMRO2, and CBF, preserving the cerebral
regulation system and self-avoiding hypotension.
Objective The objective of this paper is to review on this topic, linking themain drugs,
side effects, costs, anxiolytic properties, anticonvulsants, and correlating them with
complacency and brain metabolism.
Methods We perform a literature review using PubMed database, MEDLINE, EMBASE,
Science Direct, The Cochrane Database, Google Scholar, and Clinical trials. We selected
papers from the period between 1958 and 2014, which totaled 254 papers. Of these,
we selected 129 papers based on keywords, inclusion, and exclusion criteria.
Evidence Review The volume of the brain decreases due to dislocation of the CBVout
of the skull. The main sedatives and analgesics are propofol, midazolam, etomidate,
ketamine, barbiturates, dexedetomedina, morphine, fentanyl, alfentanil, sulfenatil,
and remifentanil. We hereby discuss the algorithm for a fast intubation sequence and
the algorithm for intracranial hypertension treatment regarding the systematic
sedation therapy. A range of sedatives and analgesic agents are available for sedation.
Each class has its own positive and negative effects on neurotrauma patients.
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Introduction
Trauma is a leading cause of death in people between 1 and
44 years. Traumatic brain injury (TBI) is the main determi-
nant of morbidity, disability, and mortality within this age
group. Severe TBI is associated with a 30 to 70% mortality
rate, and the recovery of survivors is marked by severe
neurological sequels and a severely impaired quality of life.
TBI means any aggression traumatic order that results in
anatomic injury or functional impairment of the scalp, skull,
meninges, the brain or its vessels.1,2
Brain injuries and their coverage occur in 200 out of
100,000 people per year and account for 14 to 30 deaths
among 100,000 people per year in the United States. The
most common cause of TBI is through vehicles, followed
by falls from heights (pediatric and geriatric predominates
in this group), and by ﬁrearms. The incidence in men is
two to three times higher than in women and the most
common age range is from 15 to 24 years, with a second-
ary peak after 65 years. The seriousness of the problem is
complicated by behavioral sequelae, even in relatively
small head injuries.3,4
Sedatives and analgesics are agents commonly used in
critically ill patients. The use of sedatives in neurotrauma
patients in both the operating room and the intensive care
unit is extremely important to know what effects these
drugs or drug combinations have on brain metabolism and
intracranial compliance. Cerebral vasodilation may result
in increased intracranial pressure (ICP) or oxygen
consumption (CMRO2). In addition, these agents can affect
the cerebral perfusion pressure (CPP), as many have
potent effects on mean arterial pressure (MAP). Other
concerns involving the use of these agents include time
until wake-up after the interruption and the effects on
patient outcome. Cost is also becoming an increasingly
important factor to consider in the choice of drug
therapy.5
Severe trauma patients present with risk of hypoten-
sion and cerebral vasodilation due to brain injury. Hypo-
tension reduces cerebral perfusion pressure, cardiac
output, and peripheral resistance. Self-regulation persists
only in the blood pressure range of 60–150mmHg. Differ-
ent values start to trigger the mechanisms of brain
swelling and impaired cerebral metabolic physiology,
like increases of cerebral vasodilation (CVS), cerebral
swelling, CMRO2 and ICP.6
Objective of this study is to perform a literature review on
the main effects of analgesia and sedation in severe TBI,
relate the main drugs and their effects, correlating with
metabolism and brain compliance. We also propose algo-
rithms for rapid sequence intubation in TBI and intracranial
hypertension to systematize the sedation therapy.
Conclusions The correct analysis of sedation and analgesia in neurotrauma, rapid
sequence intubation, andmanagement of medications in intracranial hypertension can
lead to an ideal management of brain injury.
Resumo Introdução Traumatismo Craniano (TCE) é determinante direto na morbidade,
incapacidade e mortalidade na população jovem. Sedativos e analgésicos são comu-
mente usados em pacientes com lesão cerebral com o objetivo de recuperar PIC,
CMRO2 e FBC, preservando o sistema de autorregulação cerebral, evitando hipotensão.
Objetivo O objetivo deste trabalho é fazer uma revisão sobre este tema, correlacio-
nando as principais drogas, efeitos colaterais, custos, propriedades ansiolíticas,
anticonvulsivantes, correlacionando com complacência e metabolismo cerebral.
Métodos Revisão da literatura utilizando base de dados PubMed, MEDLINE, EMBASE,
Science Direct, The Cochrane Detabase, Google Scholar, ensaios clínicos. Os trabalhos
selecionados de 1958 a 2014. Somou-se 254 trabalhos. Foram selecionados 129,
através de palavras-chave, inclusão e critérios de exclusão.
Evidência Revisão O volume do cérebro é reduzido devido o deslocamento do
volume cerebral. Os principais sedativos e analgésicos são: propofol, midazolam,
etomidato, cetamina, barbitúricos, a dexmedetomidina, morﬁna, fentanil, alfentanil,
sulfato, remifentanil. Discute-se algoritmo para a sequência rápida de intubação e
algoritmo para tratamento de hipertensão intracraniana. Uma série de sedativos e
analgésicos agentes estão disponíveis para sedação. Cada classe tem seu próprio
efeitos positivos e negativos em pacientes no neurotrauma.
Conclusões e Relevância O presente trabalho contribui com a análise correta da
sedação e analgesia em neurotrauma, sequência rápida de intubação e administração
de medicamentos para analgesia e sedação em hipertensão intracraniana, e um ideal
manejo na lesão cerebral.
Palavras-chave
► lesão cerebral
► hipertensão
intracraniana
► sedação
► analgesia
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Materials and Methods
We conducted a literature review using as a database
PubMed, MEDLINE, EMBASE, Science Direct, the Cochran
Database, Google Scholar, and Clinical Trials. We selected
works from the period of 1958 to 2014. There were a total of
254 works, from which 129 were selected according to
exclusion criteria. We also performed a manual search in
medical journals and magazines regarding the brain metab-
olism in severe TBI. Articles with incomplete clinical data
were not included in thework.We also deleted those focused
on TBI approach, surgical types, and behaviors of cerebral
injury. The main topics determined are presented below.
Sedation and Analgesia
Knowledge of brain metabolism is very important to un-
derstand the braińs self-protection mechanisms in the face
of acute brain injury. The brain volume decreases simply
because of the partial displacement of the cerebral blood
volume (CBV) outside the skull with head elevation (single
measure for drainage of venous blood), control mean arte-
rial pressure (MAP), cerebral perfusion pressure (CPP),
cerebrospinal ﬂuid drainage, stimulation of vasoconstric-
tion inducers brain (hypercapnia), and decreased chest
compressions. The mechanisms are centered in: mainte-
nance of cerebral autoregulation, reduced cerebral con-
sumption (cerebral metabolic rate for oxygen - CMRO2),
and cerebral blood ﬂow (CBF).7–20
Agents that lead to cerebral vasoconstriction are benzo-
diazepines, etomidate, propofol, lidocaine, and barbiturates
(from smallest to greatest effect). They can behave differently
depending on the applied dosage. The followingmedications
have the effect of (a) reducing cerebrospinal liquor: fentanyl,
halothane isoﬂurane, pentobarbital, nitrous oxide; (b) in-
creasing cerebrospinal liquor: enﬂurane and ketamine; (c)
reducing the ICP: thiopental, etomidate, lidocaine, benzodi-
azepine, droperidol, and narcotics; and (d) increase ICP:
halothanes, enﬂurane, succinylcholine, and isoﬂurane.
►Table 1 shows the relationship of analgesia and sedation
drugs with their pharmacological characteristics.21–30
Sedation has a signiﬁcant effect on energy expenditure. In
postoperative patients, an increase in the depth of sedation
progressively decreased metabolism. There is a reduction in
VO2 after the application of adequate diet in sedated pa-
tients.31 The goal of controlled hypothermia with sedation
and neuromuscular blockade (NMB) in patientswith TBI is to
reduce intracranial hypertension, avoiding coughing and
agitation into the fan, and to eliminate tremors.32–35
Malnutrition has been associated with increased morbid-
ity and mortality and prolonged length of stay. Providing
optimal caloric intake is important, especially in intensive
care units. Resting energy expenditure (REE) for patients
with cerebral lesions was estimated between 40 and 200%
higher than a person not injured. This energy expenditure
can be reduced with appropriate sedation.36–40
Evidence suggests that continuous infusion of sedatives
and opioids may increase the duration of mechanical venti-
lation (MV) and contributes to pneumonia and ventilator
associated bloodstream infections. A strategy to prevent the
accumulation of sedatives and opioids is the use of sedatives
with daily interruptions and spontaneous breathing at-
tempts to reduce the duration of MV and hospital time.41–50
The use of sedation protocols proved effective with a
reduction in the duration of MV, hospital stay and use of
drugs, but has been limited primarily to medical intensive
care unit (ICU) patients. Therefore, a multidisciplinary team
is required to develop a protocol for analgesia and sedation,
aiming to standardize the process of keeping patients calm
and cooperative.26,27
The benzodiazepines are central nervous system (CNS)
depressants and anticonvulsants, which also increase sei-
zure threshold; they are not painkillers. They stimulate the
GABA receptors. This drug act in sedation, anxiolysis, and
amnesia effect. Themuscle relaxant property is via the spinal
cord. It is lipid-soluble and quickly penetrates the blood-
brain barrier. Onset of action is short, producing minimal
cardiovascular effects that are contraindicated in hypovole-
mic patients.51 Association of opioids and benzodiazepines
are synergies in situations that require a vigorous sedation. If
there is high left ventricular pressure, the association of
diazepam and midazolam has a “nitroglycerin effect,” low-
ering blood pressure and increasing cardiac output. Drugs in
Neurotrauma can decrease the CBFaswell as CMRO2, ICP, and
CBV. There is a plateau of maximal effect due to saturation of
the receptors. Midazolam may reduce alpha activity, an
increased theta and delta-® activity. In the EEG (electroen-
cephalogram). This effect of midazolam will be represented
with low voltage in EEG. Midazolam is unable to produce a
standard surge suppression in the EEG. It does not affect
responses in somatosensory-evoked potential. Midazolam
provides greater protection against hypoxia than diazepam.
The ﬂumazenil decreases MAP, increases ICP, but has little
effect on CMRO2.52–59
Opioids have properties similar tomorphine. Each receiv-
er has a function. The sigma receptor is related to dysphoria,
hallucinations, and respiratory stimulation. The μ1 relates to
analgesia and bradycardia urinary restraint; whereas the μ2
is responsible for analgesia, respiratory depression, physical
dependence, and constipation. The Kappa receptor is related
to analgesia, sedation and dysphoria. Finally the DELTA
receiver is responsible for analgesia, respiratory depression,
physical dependence and urinary retention. Agonists such as
pethidine (meperidine), fentanyl and causes less gastric
hypomotility, biliary spasm, and has little effect on the
breathing pattern.60 Synthetic (fentanyl) has high lipid solu-
bility and rapid onset of action without cardiovascular
damage. Meperidine increases heart rate. Morphine, fenta-
nyl, sufentanil, alfentanil, remifentanil cause vagus-mediat-
ed bradycardia. Meperidine and morphine are histamine-
inducing, leading to a decrease in blood pressure, systemic
vascular resistance, and bronchospasm. Opioids lead to
stiffness of the chest wall and increased progressive muscle
tone mediated by the μ receptors in supraspinal muscles in
the raphe nucleus and on the bridge.61 It provides slower
gastric emptying, reducing peristalsis, and biliary spasm.
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Moreover, it reduces CMRO2, cerebral blood ﬂow, and ICP
(intracranial cerebral pressure), reduces MAP and CPP. Su-
fentanil, alfentanil, and fentanyl in ICP has transient increase
in ICP after peak ﬁve minutes, returning to normal in 15
minutes.62 This transient increase in ICP can lead to muscle
stiffness and opioid-induced histamine release. There are
few studies on remifentanil, which has signiﬁcant effects on
ICP, with no change in brain metabolic dynamics with rapid
awakening.63–67
Barbiturates have anticonvulsant properties and cause
CNSdepression. Theyactivate theGABA receptors and inhibit
AMPA excitatory receptors. Thiopental or pentobarbital acts
by decreasing ICP, refractory epilepsy, and ischemic protec-
tion. These agents are lipophilic, metabolized in the liver by
the cytochrome P450. They have a short duration and rapid
distribution to fat. Constant EEG monitoring is necessary
until there is a pattern of suppression outbreak in EEG.68–75
Propofol has high lipid solubility, rapid onset of action,
and short half-life of 2 to 8 minutes. Promotes profound
decrease in MAP, fall in systemic vascular resistance, cardiac
contractility, deep brain depression. Decreases CMRO2, CBF,
and ICP in patients with brain injury. Propofol decreases the
release of L-aspartate and L-glutamate. They are plasma
antioxidant, useful in neurosurgery patients. DiprivanTM
(Astrazeneca, London, UK), is a special propofol, it contains
EDTA as a preservative while the generic product uses
sulﬁdes. EDTA is a chelating calcium, which is neuroprotec-
tive in combination with propofol.76–86
Etomidate has better metabolic behavior in cerebral than
barbiturates. Unlike these, etomidate little changes the car-
diovascular metabolism. It is lipophilic, with rapid penetra-
tion to the brain and other tissue.87 The drug is metabolized
in blood and liver and excreted in urine (75%), stool (13%),
and bile (10%). Its effect on ventilation is minimal. The
medication is associated with myoclonus incidence, howev-
er, reduce endogenous cortisol production. Supplementation
of vitamin C can restore the cortisol levels. It has low
solubility in water, resulting from the use of a propylene
glycol vehicle, which leads to hyperosmolarity, intravascular
hemolysis, renal insufﬁciency, acidosis, and lactate accumu-
lation. There are records of complications such as thrombo-
phlebitis, phlebitis, and pain on injection. The effect on EEG is
equal to that of thiopental. It prolongs survival during
hypoxia or ischemia. Glycine and glutamate levels were
reduced in the group treated with etomidate.88–91
Ketamine interacts with N-methyl-D-aspartate (NMDA)
receptor, similar effects can mediate analgesia, inhibiting
dorsal horn of spinal cord. Thismedication of sedative action,
amnesia, and analgesic properties increases heart rate, MAP,
pulmonary artery pressure increases, hear attack chance and
myocardial oxygen consumption, and potent bronchodila-
tor.92 Ketamine also increases CMRO2 and ICP. This increase
can be blocked by the administration of thiopental or diaze-
pam; combinations are an option in patients with TBI.
Midazolam and ketamine association provides small in-
creases in CBF, ICP, and CMRO2; whereas, propofol provides
no increase. Ketamine can also lower the seizure
threshold.93–97
Neuroleptics are of great importance for the control of
sedation, anxiolysis, and analgesia. Haloperidol is widely
protein binding (> 90%) and metabolized by hepatic glucur-
onidation that induce ventricular arrhythmias (i.e., Torsade
de Pointes), QTi increases, as well as reductions in the
relationship between the CBF, CMRO2, and ICP.98 The cloni-
dine and dexmedetomidine have neuroprotective effects in
cerebral ischemia.99–102
The halothanes have vasodilatory effect mitigated when
associated with intravenous anesthetics that cause cerebral
vasoconstriction.103
The isoﬂurane increases CBF less than halothane does.
Barbiturates reduce total peripheral resistance, lowering
blood pressure, and consequently also decreasing CBF,
CMRO2, and ICP, which may depress electrical and ischemic
activity.104
Lidocaine (1 mg/kg) reduces the ICP and the reﬂection of
tracheal intubation. Although it reduces CMRO2 and CBF, in
larger doses it becomes toxic and causes seizures, greatly
increasing CBF and CMRO2.105
Neuromuscular blockers are used duringmechanical ven-
tilation in patients with severe respiratory insufﬁciency and
in the treatment of patients with intracranial hypertension,
avoiding the use of succinylcholine as it may induce increase
of intracranial hypertension. They should only be used after
adequate sedation and analgesia. The pancuronium curare is
preferable for patients with renal function, normal liver, and
cardiac and hemodynamic stability.106 The vecuronium, on
the other hand, should be reserved for patients with heart
disease or hemodynamic instability, inwhich the tachycardia
may be deleterious. To avoid tachycardia, it can be used for
vecuronium loading dose and pancuronium maintenance.
Atracurium should be reserved for patients with renal
impairment (CrCl < 10 mL/min), and hepatic impairment.
(30x greater than the cost of pancuronium). The lockmust be
monitored with Train-of -Four (TOF). Prophylaxis should be
adjusted to high risk of deep venous trombosis (DVT). In
curarized patients, the only signs of inadequate sedation can
be hypertension, tachycardia, sweating, lacrimation, and
mydriasis. In cases that occur with severe intracranial hy-
pertension, the decision to use neuromuscular blockers is
still possible. In this case, nondepolarizing is indicated,
preferably with less hemodynamic action, such as vecuro-
nium (attack from 0.06 to 0.08 mg/kg, maintenance 0.02 to
0.03 mg/kg/hour) and atracurium (0.3 to 0.5 mg/kg, main-
tenance 0.2 to 1 mg/kg/ hour), although other agents may be
used, such as pancuronium (attack from 0.06 to 0.08 mg/kg,
maintenance 0.02 to 0.03 mg/kg/hour). When using neuro-
muscular blockers, it is important to monitor the EEG to
avoid convulsive states and, whenever possible, use t a
peripheral nerve stimulator.105
Nitric oxide (N2O) is used to reduce the consumption of
intravenous hypnotic agent and promote patient awakening
after surgery, discrete high levels of CBF. Commits brain
complacency, increasing this effect in the brain, especially
when used with halogenated agent.107,108
Dosages and associations can generate their own effects.
Thiopental further reduces the CMRO2, 50% of CBF. Fentanyl
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above 200 mcg/kg increases CMRO2, CBF, PaCO2, aside from
being epileptogenic. Etomidate in large dosages can lead
epileptic seizures. The etomidate and fentanyl association
form spicules in the EEG, which may increase seizures. Halo-
genates reduce CMRO2 and CBF, increase vasodilation, and
increase CBV, ICP, which may in turn reduce CPP.109 Propofol
andmidazolam association are beneﬁcial in cerebral hemody-
namics, ICP, and CPP. Propofol, however, may lead to hyper-
triglyceridemia. When reducing bleeding hypotension is
required, thiopental or isoﬂurane decrease total peripheral
resistance and blood pressure. Fentanyl, morphine, sufentanil,
ketamine, and sufentanil increase the ICP, decreases MAP and
CPP. Ketamine and sufentanil have no effect on the MAP.
Phenobarbital and etomidate reduce ICP. Propofol and mor-
phine synergistically decrease ICP. Propofol and midazolam
has good association. Drugs such as calcium channel blockers,
triazole antifungal, and erythromycin inhibit midazolam
metabolism. ►Table 2 lists the major drugs used for sedation
and analgesia in trauma and their relationship with the cere-
bral dynamics and metabolism.110–112
Drug of Choice for Induction for Each Injury
In neuroanesthesia not just ﬁll the basic requirements such
as analgesia, hypnosis, neurovegetative protection and mus-
cle relaxation, should carefully examine each disease.111,112
Cerebral aneurysm, ischemia may occur by vasospasm
should be careful with hypotension. When autoregulation is
compromised will be difﬁculties in reducing CBV with
hearing impairment. If necessary blood temporary occlusion,
cerebral protection measures are necessary. if not clipped all
aneurysms should be careful with hypertension, because the
risk of rerupt.97
In brain tumor resections may have alteration of cardio-
vascular, respiratory and level of consciousness. When ex-
tensive peritumoral area with compromised edema or self-
regulation, there may be difﬁculty in reducing brain volume
through anesthetic maneuvers. The bleeding in the tumor
area after resection, we needmild hypotension regime in the
immediate postoperative period.113
If the ICP is high, there may be cardiovascular changes at
the decompression. 114 Traumatic brain injury as the worst
Glasgow more likely to be little vascular reactivity.114
In spinal cord injurymay experience difﬁculty ventilatory
due to lack of movement of the chest muscles, indicating
immediate endotracheal intubation and mechanical ventila-
tion to prevent hypoxemia. The friendly spinal injury high
level exacerbates the parasympathetic activity and at the
time of tracheal intubationmayoccur reﬂex bradycardia and
cardiac arrest. The total peripheral vasoplegia, due to the
sympathetic injury, causing signiﬁcant hypotension. In this
situation hypotension should be corrected with volume
infusion associated with vasopressor drug titrated way,
and should avoid the use of anesthetics that cause depression
of the cardiovascular system.
With the exception burnt, intravenous drugs reduce the
CBF and CMRO2, which is a good indication for patients with
high ICP because they reduce CBV. On the other hand fully
intravenous anesthetic technique choice may hinder the
early awakening of the patient difﬁcult neurological
evaluation.115–117
Resection of AVM (arterial venous malformation) produ-
ces a reduction in bleeding on thebedwherehewas the AVM,
this is achieved by hypotension. Resection causes the blood
ﬂow before passing the AVM passes by passing pathological
vessels that do not have effective self-regulation. This in-
creased supply, increases theﬂowof pathological vessels and
may have brain barrier break and brain swelling and in-
creased ICP. In this situation the barbiturate is well indicated,
until it can awaken without hypertension and bleeding. The
barbiturate coma reduce the consumption of oxygen brain
and will contract non pathological brain vessels, reducing
ICP. Barbiturate large dose (4-5 g / 24 hours), depress the
cardiovascular system that reduces cardiac output and the
total peripheral resistance, causing hypotension arterial.118
After blood temporary arterial occlusion brain for a long
time, with the use of hypothermia, the patient may experi-
ence respiratory difﬁculty in the immediate postoperative
period. This difﬁculty may be caused by temporary ischemia
due to arterial occlusion or metabolic changes inherent to
Table 2 Drug ratio most used for sedation and analgesia, and the effects on the cerebral metabolism
Drug ICP CPP CMRO2 CBF MAP Epilepsy
action
ICP
prevention
Sedation Analgesia
Morphine   ¼ 0  0 þ þ þþþ
Benzodiazepine   ¼   þ þ þþþ þ
Propofol   <  - - þ þ þþþ þþ
Barbituric - -  < - - - - þ þ þþþ 
Etomidate  ¼ <  0 0 þ þþþ 
Curare  ¼ 0 0 0 0 þ þ þ
Ketamine  ¼ ¼ 0 0 0 þ þ þ
Abbreviations: CBF, cerebral blood ﬂow; CMRO2, cerebral metabolic rate for oxygen; ICP, intracranial pressure; MAP, mean arterial pressure; CPP,
cerebral perfusion pressure; 0, without contributions; þ, increase; þþ, signiﬁcant increase; þþ þ , more signiﬁcant increase -, reduction; - -,
signiﬁcant reduction; - - -, more signiﬁcant reduction.
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hypothermic, dehydration and the use of anesthetic large
quantidade.118
Tumors in thehypothalamus region of stem and bulb, near
lower cranial nerves, usually have cardiorespiratory prob-
lems in the postoperative period.
Patients with pulmonary disease, obese, with breathing
difﬁculties andpatientswithmultiple associated diseases that
increase postoperative morbidity, should be kept intubated.
Should choose drugs that have fast metabolism and excretion,
as propofol, etomidate and analgesics short duração.118
Ideal Sedation for Neurocritical Patients
The medications for optimal sedation of neurocritical pa-
tients must start and end fast, as well as provide predictabil-
ity of action to target organs, be easily titrated, and able to
reduce ICP by reducing blood volume or cerebral vasocon-
striction, reducing CBF and CMRO2. At the same time, they
must keep the CBF / CMRO2 combination, maintain cerebral
autoregulation, allowing cerebrovascular reactivity varia-
tions of PaCO2, minimal cardiovascular depression, brain
tissue recovery, and prevent secondary neuronal damage.
This allows neurological evaluation, limiting the stress re-
sponse to critical illness, protecting the brain during ische-
mia by metabolic depression, attenuating the release of
catecholamines induced by ischemia, increasing vascular
resistance of non-ischemic areas, increasing glucose plasma
a2-adrenergic inhibition by insulin. Patients using these
drugs need to be monitored through the use of capnography,
ICP, MAP, CPP, transcranial Doppler. The level of sedation and
adaptations to fan can be monitored by clinical parameters
such as SAS, RASS, Ramsay, and Glasgow scales. Use of BIS
Fig. 1 Algorithm intubation in the emergency room. Abbreviations: AMBU®, bag valvemask; BNM, neuromuscular block, CPR, cardiopulmonary
resuscitation; TOT, endotracheal intubation.
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(Bispectral index) has been of great value for monitoring
sedation since it encodes the EEG traces into digital values
ranging from 0 to 100. Values between 90 and 100 mean the
patient is awake and between 45 and 60means the patient is
adequately anesthetized.113–120
The pharmacokinetics of drugs depends of absorption,
distribution, metabolism or biotransformation, and excre-
tion of drugs. In brain injury, disruption of the blood-brain
barrier and changes in the binding protein can modify the
drugś pharmacokinetics. Perfused organs receive dispropor-
tionately large amounts of the drug compared with poorly
perfused organs. The elimination of the drug occurs in two
stages. First occurs through oxidation and reduction reac-
tions, cytochrome P-450 and hydrolytic reactions. Second is
through conjugation reactions of the drug or its metabolite
with an endogenous substrate, such as D-glucuronic acid.
The drugs cross biologic membranes. The kidney is the main
excretor.119–121
One study found that pre-hospital intubation may in-
crease mortality. Mortality of intubated patients in trauma
scene was 93%, compared with 67% mortality that were
intubated in hospital. This statistic persists even when
adjusted for age, Glasgow score, associated injuries, and
injury mechanism. The increased mortality pre-hospital is
due to lower staff training regarding the rapid sequence
intubation procedure and the greater frequency of more
severe patients in pre-hospital care. The bias of this study
is the selection bias of patients since patients scene end up
being worse.118,119
The anticonvulsant action of sedatives is widely used in
clinical practice. Risk factors for early posttraumatic seizures
are: Glasgow below 10, injury, subdural or epidural hemato-
ma, penetrating injury, and convulsions in the ﬁrst 24 hours.
The drugs with superior results were barbiturates, propofol,
and benzodiazepines. Early prevention of seizure does not
diminish late epilepsy after trauma. Phenytoin and carba-
mazepine are also very effective in the seizure post early
trauma prevention.121–125
Neurological patients often present autonomic disorders.
Sedatives and analgesics, as well as neuroleptics, can
Fig. 2 Algorithm for treatment of patients with intracranial pressure in the emergency room. Abbreviations: EEG (electroencephalogram); ICP
(intracranial pressure). Source: Brain Trauma Foundation. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007;
24(Suppl1):s37-s44.
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contribute for treatment. Themain usage ofmedications that
avoid hypertension, tachycardia, tachypnea, hyperthermia,
sweating triggered by autonomic disorders, and their effects
on the central nervous system.126
Discuss in this paper the non-pharmacological sedation
procedure to help these patients. It involves respect family /
patient / staff. Decreased volume monitoring equipment,
active and passive mobilization of the patient, respecting
the circadian cycle, family stay with patient and even use
personal songs in hospital.127
The reversal of drugs frequently occurs in neurological
patients. Neuromuscular blockers reverse with Prostig-
mine® (0.25 to 0.35 mg/kg) and atropine (20 mg/kg), which
can increase the ICP. Theﬂumazenil (0.1 to 0.4mg/kg) used to
reverse the benzodiazepines may cause tachycardia, hyper-
tension, and increase CMRO2. The naloxone (0.4 to 2 mg) to
reversal opioids. Benzodiazepines may lead to reactive bilat-
eral mydriasis. The treatment uses up morphine or metha-
done or clonidine associated to treatment with anxiolytics
and sedatives.
Neuronal activity and apoptosis are stimulated by electri-
cal activity of the brain on NMDA receptors in two ways
depending on the receiver’s position in the cell. Synaptic are
neuroprotective, related to neuronal activity. The extrasy-
naptic NMDA receptors are related to cell death or reduction
of neuronal activity and decrease of CPP and MAP.89 Deep
sedation reduces neuronal activity, loss of neurons, and
functional neurological impairment. Tissue repair after acute
brain injury occurs when there are activationmechanisms of
brain development. Deprivation of neural activity with anti-
convulsants also had adverse effects after brain injury with
stimulation of extrasynaptic receptors. Pretreatment with
midazolam or isoﬂurane can lead to cell death and worse
results in rats acutely brain injury.
This paper contributes to the literature with two algo-
rithms, presented in ►Figs. 1 and 2, regarding the medica-
tions used in rapid sequence intubation and management of
intracranial hypertension.
Conclusion
A range of sedative and analgesic agents are available for
sedation. Each class has its own positive and negative effects
in critically ill neurotrauma patients. There are few studies,
which are limited to tests performed during elective neuro-
surgical procedures or in healthy volunteers in the brain
metabolism works on physiological thresholds. Thus, data
must be applied cautiously for neurocritical patients. The
preference for certain agents should be based on a thorough
understanding of the effects on brain metabolism and intra-
cranial compliance. The ideal medication is one that com-
bines reduced LCR, increase less CBF and CBV, increase CPP,
anddecrease the IPCwithoutmuchdecrease toMAP. It is best
to avoid the use of inhaled halogenates since they vasodilate
the brain, which worsens the brain hemodynamics. It is
preferable to use intravenous sedatives. The target for the
use of these agents is to optimize the care of critically ill
patients in neurotrauma without affecting the ability to
assess the patient clinically to limit the secondary neuronal
damage due to pain agitation and sedation. The correct
analysis of sedation medications and analgesia in neuro-
trauma, with rapid sequence intubation and management of
medications in intracranial hypertension, provide a correct
handling in the brain.
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